SHANGHAI PHARMACEUTICALS HOLDING CO revenue breakdown overview

SHANGHAI PHARMACEUTICALS HOLDING CO revenue for the last year amounted to 286.36 B HKD, the most of which — 252.32 B HKD — came from its highest performing source at the moment, Distribution, the year earlier bringing 233.45 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI PHARMACEUTICALS HOLDING CO 282.84 B HKD, and the year before that — 265.58 B HKD.